Correlation Engine 2.0
Clear Search sequence regions


  • canada (6)
  • child (2)
  • child preschool (1)
  • children (2)
  • drug industry (1)
  • female (1)
  • humans (1)
  • infant (1)
  • infant newborn (1)
  • monographs (7)
  • neonates (1)
  • Sizes of these terms reflect their relevance to your search.

    Optimal drug therapy in children relies on the availability of pediatric-specific information. We aimed to describe the current status of pediatric pharmacotherapy data in monographs of new drugs approved by Health Canada. In this descriptive analysis, we reviewed the quality and quantity of monographs of new drugs approved by Health Canada between Jan. 1, 2007, and Dec. 31, 2016. We excluded drugs withdrawn from the Canadian market and drugs with primary indications irrelevant to pediatrics. We determined the percentage of included drug monographs that listed pediatric-specific information. During this study period, Health Canada approved 281 drugs, 270 of which met our inclusion criteria. Pediatric-specific information and indication were present in 127 (47.1%) and 75 (27.8%) of the drug monographs, respectively. Of all pediatric age groups, neonates had the lowest number of indications listed in the product monographs (7, 2.6%). Only 9 (60%) oral drugs indicated for children 6 years of age or younger were available in child-friendly, age-appropriate dosage forms. Most of the new drugs approved by Health Canada do not contain pediatric or neonatal indications in their product monographs, and therefore, are used "off-label." Regulatory mechanisms are required to promote both neonatal and pediatric drug development and submission of available pediatric data by manufacturers to Health Canada. Copyright 2020, Joule Inc. or its licensors.

    Citation

    Preeya Raja, Mark Duffett, Maryann Mazer-Amirshahi, Ashaka Patel, Andrea Gilpin, Catherine Litalien, Anthony K Chan, John van den Anker, Thierry Lacaze-Masmonteil, Samira Samiee-Zafarghandy. Pediatric drug data in Canadian drug monographs: a descriptive analysis. CMAJ open. 2020 Jul-Sep;8(3):E522-E529

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32873580

    View Full Text